Lewis K, Maio M, Demidov L, et al. BRIM8: a randomized, double-blind, placebo-controlled study of adjuvant vemurafenib in patients (pts) with completely resected, BRAFV600+ melanoma. ESMO 2017, abstract LBA7_PR.
Sotorasib plus panitumumab bij refractair colorectaal carcinoom met KRAS G12C-mutatie
dec 2023 | Maag-darm-leveroncologie